FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
Xeris Pharmaceuticals Inc. (NASDAQ: XERS) reported Q1 EPS of ($0.89), in-line with the analyst estimate of ($0.89). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.43 million.
Starting in January with the field launch, Gvoke PFS began to see a very... More

